Immune Checkpoint Inhibitors in Advanced NSCLC: [18F]FDG PET/CT as a Troubleshooter in Treatment Response.

Cristina Ferrari Giulia SantoNunzio MerendaAlessia BrancaPaolo MammucciPamela PizzutiloCosmo Damiano GadaletaGiuseppe Rubini

Published in: Diagnostics (Basel, Switzerland) (2021)

[18F]FDG PET/CT by using interval changes of PET-derived semi-quantitative parameters could represent a reliable tool in immunotherapy treatment response evaluation in NSCLC patients.

Keyphrases

small cell lung cancer
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
computed tomography
peritoneal dialysis
prognostic factors
high resolution
tyrosine kinase